SCHEMBL25839306

SCHEMBL25839306

CN(C)S(=O)(=O)c1ccncc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
HTT P42858 1/20 0.40
KDM4E B2RXH2 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MEN1 O00255 1/20 0.39
KDM6B O15054 1/20 0.39
KDM4A O75164 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4D Q6B0I6 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CA12 O43570 7/20 0.39
CA2 P00918 7/20 0.39
CA9 Q16790 7/20 0.39
CA1 P00915 6/20 0.39
CA14 Q9ULX7 6/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25838457 0.85 ALDH1A1 (0.43) ALDH1A1HTTKDM4EL3MBTL1CA12
SCHEMBL18230499 0.79 KDM4E (0.47) ALDH1A1KDM4EL3MBTL1MEN1KDM6B
SCHEMBL30050575 0.79 KDM4E (0.47) ALDH1A1KDM4EL3MBTL1MEN1KDM6B
SCHEMBL31173473 0.78 CA12 (0.40) ALDH1A1HTTKDM4EL3MBTL1MAPT
Hydrochloric Acid SCHEMBL18228076 0.77 KDM4E (0.46) ALDH1A1KDM4EL3MBTL1MEN1KDM6B
SCHEMBL394382 0.76 CA12 (0.55) ALDH1A1KDM4EL3MBTL1MEN1KDM6B
SCHEMBL27619565 0.75 KDM4E (0.47) ALDH1A1KDM4EL3MBTL1MEN1KDM6B
SCHEMBL25838445 0.74 GSTO1 (0.44) ALDH1A1KDM4EL3MBTL1CA12CA2
SCHEMBL30908488 0.72 GAA (0.58) ALDH1A1HTTCA12CA2CA9
SCHEMBL1439407 0.72 GAA (0.58) ALDH1A1HTTCA12CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4464699-A1 PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF Lisen Therapeutics, Inc. (US) 2024-11-20 EP disclosed
US-20240360145-A1 PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF LISEN THERAPEUTICS, INC. 2024-10-31 US disclosed
WO-2023134582-A1 PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF 上海立森印迹医药技术有限公司 2023-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240360145-A1 PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF DPYD, TYMP, TYMS ALDH1A1 406/4885HTT 3593/4885KDM4E 2411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.